Drug Shortage Report for MINT-ROSUVASTATIN
Report ID | 71081 |
Drug Identification Number | 02397803 |
Brand name | MINT-ROSUVASTATIN |
Common or Proper name | Rosuvastatin |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-01-03 |
Estimated end date | 2019-01-31 |
Actual end date | 2019-01-31 |
Shortage status | Resolved |
Updated date | 2019-02-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-03 | English | Compare |
v2 | 2019-01-03 | French | Compare |
v3 | 2019-01-04 | English | Compare |
v4 | 2019-01-16 | English | Compare |
v5 | 2019-01-16 | French | Compare |
v6 | 2019-01-31 | English | Compare |
v7 | 2019-01-31 | French | Compare |
v8 | 2019-02-01 | English | Compare |
Showing 1 to 8 of 8